Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer - Concepedia

Concepedia

Publication | Closed Access

Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer

76

Citations

34

References

2020

Year

Talia Golan, Alex Barenboim, Guy Lahat, Ido Nachmany, Yacov Goykhman, Einat Shacham‐Shmueli, Naama Halpern, Eli Brazowski, Ravit Geva, Ido Wolf,

Annals of Surgical Oncology

Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineNeoadjuvant FolfirinoxBrca Mutation CarriersPathologyPancreatic SurgeryCancer TreatmentOncologyRadiation OncologyCancer ResearchComplete Pathologic Response

References

	Year	Citations

Page 1

Page 1